The Role of Signal Transduction Pathways in Hypertension
信号转导途径在高血压中的作用
基本信息
- 批准号:7281775
- 负责人:
- 金额:$ 3.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2008-05-14
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerol1-Phosphatidylinositol 3-KinaseAdaptor Protein Complex 1AddressAdrenal GlandsAffectAffinityAngiotensin IIAngiotensin II ReceptorAngiotensin II Signaling PathwayAngiotensinsAnimal ModelAnimalsApoptosisAreaAttentionAttenuatedBaroreflexBindingBiologicalBlood - brain barrier anatomyBlood CirculationBlood PressureBlood VesselsBradycardiaBrainBrain StemBrain regionCardiacCardiopulmonaryCardiovascular PhysiologyCardiovascular systemCatecholaminesCell NucleusCell membraneCellsCharacteristicsChemoreceptorsChronicChymosinComparative StudyComplexConsciousDepositionDepressed moodDevelopmentDiglyceridesDiseaseDisease ProgressionDopamineDorsalDoseEnvironmental Risk FactorEnzymesEpidermal Growth FactorEssential HypertensionEtiologyEventExhibitsExtracellular MatrixFellowshipFiberFingerprintFunctional disorderG-Protein-Coupled ReceptorsGTP BindingGTP-Binding ProteinsGenesGeneticGenetic ModelsGenetic Predisposition to DiseaseGenetic TranscriptionGoalsGrowthHandHeartHeart RateHigh Blood PressureHomeostasisHormonesHourHumanHydrolysisHypertensionHypothalamic structureIn VitroInbred SHR RatsInbred WKY RatsIndividualInflammationInositolIntakeInvestigationIsoenzymesKidneyKnowledgeLaboratoriesLeadLinkLiquid substanceMAPK14 geneMaintenanceMarshalMedialMediatingMedulla OblongataMetabolicMicroinjectionsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMixed Function OxygenasesModelingMorbidity - disease rateMusNamesNeonatalNerveNeuraxisNeuronsNeurotransmittersNorepinephrineNucleus solitariusNumbersOutputPIK3CG genePartner in relationshipPathogenesisPathway interactionsPatientsPatternPeptidesPeripheralPharmaceutical PreparationsPharmacological TreatmentPhenotypePhosphatidylinositolsPhospholipase CPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionPreparationPressoreceptorsProcessProductionProtein-Serine-Threonine KinasesRas/RafRattusReceptor, Angiotensin, Type 1RegulationRenal functionReninRenin-Angiotensin SystemReportingResearchResearch DesignRoleSeriesSignal PathwaySignal TransductionSignal Transduction PathwaySiteSprague-Dawley RatsStimulusStructure of area postremaSympathetic Nervous SystemSystemThreonineTissuesTransgenic ModelTransgenic OrganismsTyrosine 3-MonooxygenaseTyrosine PhosphorylationValidationVariantVascular Smooth MuscleVasoconstrictor AgentsVasomotorVasopressinsYangarterioleattenuationauthoritybaseblood pressure regulationbrain tissuecell growthconceptcytokinedensityfallsgranulocytein vivoinsightinterestkinase inhibitormigrationmonocyte colony stimulating factormortalitynoradrenaline transporternormotensivepressurepreventprotein protein interactionraf Kinasesreceptorresponserodent genomesensory neuron specific sodium channelstress activated protein kinasetoolvasoconstrictionwortmanninzygote
项目摘要
DESCRIPTION (provided by applicant): The goal of the planned research is to either confirm or refute the presence of separate phosphatidylinositol 3 (PI3) and mitogen-activated protein (MAP) kinase pathways in the nucleus tract solitarius (NTS) in various models of hypertension. The overall objective is to investigate the signaling mechanisms at this brain site potentially contributing to development and maintenance of sustained hypertension. Our ongoing studies are designed to provide initial information about the relationship between the apparent enhancement of the sympathetic nervous system in various forms of hypertension and the role of PI3 and MAP kinase signaling pathways in the maintenance of hypertension. Our initial goal is to demonstrate that PI3 and MAP kinase signaling pathways in the NTS of (mRen-2)27 transgenic rats are activated in response to Ang II binding to AT1 receptors. The rationale for the proposed research is that, once knowledge of the mechanisms that are responsible for the development of hypertension has been obtained, it may lead to new strategies that can be used to prevent and/or treat hypertension, thereby reducing the morbidity and mortality associated with high blood pressure.
描述(由申请人提供):计划研究的目的是证实或反驳各种高血压模型中孤束核(NTS)中存在单独的磷脂酰肌醇3(PI 3)和促分裂原活化蛋白(MAP)激酶通路。总体目标是研究在这个大脑部位的信号机制,可能有助于持续性高血压的发展和维持。我们正在进行的研究旨在提供有关各种形式的高血压中交感神经系统的明显增强与PI 3和MAP激酶信号通路在维持高血压中的作用之间关系的初步信息。我们的初步目标是证明,PI 3和MAP激酶信号通路在NTS的(mRen-2)27转基因大鼠被激活,响应于血管紧张素II结合到AT 1受体。提出这项研究的理由是,一旦获得了导致高血压发展的机制的知识,它可能会导致可用于预防和/或治疗高血压的新策略,从而降低与高血压相关的发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Exazevia M Logan其他文献
Exazevia M Logan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Exazevia M Logan', 18)}}的其他基金
The Role of Signal Transduction Pathways in Hypertension
信号转导途径在高血压中的作用
- 批准号:
7149459 - 财政年份:2006
- 资助金额:
$ 3.01万 - 项目类别:














{{item.name}}会员




